Abstracts tagged "Arthroplasty"

Abstract Number: 1029 • 2017 ACR/ARHP Annual Meeting
What to Measure after Arthroplasty? Confirmation of a Core Domain Set
Anh Hoang¹, Susan M. Goodman², Mark P. Figgie³, Mathias Bostrom⁴, Douglas Padgett⁴, Lisa A. Mandl^5,6,7, Peter Sculco⁸, Alexander McLawhorn⁹ and Jasvinder A. Singh¹⁰, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ³Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁴Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, ⁵Department of Medicine, Hospital for Special Surgery, New York, NY, ⁶Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁷Department of Rheumatology, Hospital for Special Surgery, New York, NY, ⁸Orthopaedic Surgery, Hospital for Special Surgey, New York, NY, ⁹Hospital for Special Surgey, New York, NY, ¹⁰Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The Outcomes Measures in Rheumatology Trials (OMERACT) TJR Working Group has proposed six core domains that would constitute a standardized measurement set that can…
Abstract Number: 2755 • 2017 ACR/ARHP Annual Meeting
Comparative Risk of Biologic Therapies in Patients with Rheumatoid Arthritis Undergoing Elective Arthroplasty
Michael D. George¹, Joshua Baker², Kevin Winthrop³, E Alemao⁴, Lang Chen⁵, SE Connolly⁴, TA Simon⁴, Qufei Wu⁶, Fenglong Xie⁷, Shuo Yang⁷ and Jeffrey R. Curtis⁸, ¹Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Rheumatology, University of Pennsylvania, Philadelphia, PA, ³Oregon Health Sciences University, Portland, OR, ⁴Bristol-Myers Squibb, Princeton, NJ, ⁵University of Alabama at Birmingham, Birmingham, AL, ⁶Biostatistics and Analysis Center, University of Pennsylvania, Philadelphia, PA, ⁷Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁸Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Biologic DMARDs have varying mechanisms of action and may be associated with different infection risks. The perioperative time period is a particularly high-risk time…
Abstract Number: 2786 • 2017 ACR/ARHP Annual Meeting
Timing of Abatacept Infusions before Elective Arthroplasty and the Risk of Post-Operative Infection
Michael D. George¹, Joshua Baker², Kevin Winthrop³, E Alemao⁴, Lang Chen⁵, SE Connolly⁴, TA Simon⁴, Qufei Wu⁶, Fenglong Xie⁷, Shuo Yang⁷ and Jeffrey R. Curtis⁸, ¹Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Rheumatology, University of Pennsylvania, Philadelphia, PA, ³Oregon Health Sciences University, Portland, OR, ⁴Bristol-Myers Squibb, Princeton, NJ, ⁵University of Alabama at Birmingham, Birmingham, AL, ⁶Biostatistics and Analysis Center, University of Pennsylvania, Philadelphia, PA, ⁷Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁸Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Current guidelines recommend holding biologic DMARDs before major surgery, despite limited data. Few studies have examined perioperative timing of individual biologic therapies. This study…
Abstract Number: 2852 • 2017 ACR/ARHP Annual Meeting
Widespread Pain Prior to Total Knee Replacement (TKR) Is Associated with Increased Risk of No Clinical Improvement in Pain Among Women
Ernest Vina¹, Di Ran², Erin L. Ashbeck² and C. Kent Kwoh³, ¹Rheumatology, University of Arizona, Tucson, AZ, ²The University of Arizona Arthritis Center, Tucson, AZ, ³University of Arizona, Tucson, AZ
Background/Purpose: Up to 47% of individuals may not have clinically significant improvement following joint replacement surgery. Evidence also suggests that women are less likely to…
Abstract Number: 218 • 2017 ACR/ARHP Annual Meeting
Social Factors and Racial Disparities in Total Hip Arthroplasty Outcomes
Susan M. Goodman¹, Bella Y. Mehta², Meng Zhang³, Jackie Szymonifka⁴, Joseph T. Nguyen³, Yuo-Yu Lee³, Mark P. Figgie⁵, Michael L. Parks⁵, Shirin A. Dey⁴, Daisy B. Crego⁴, Linda A. Russell⁶, Lisa A. Mandl⁷ and Anne R. Bass⁶, ¹Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ²Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine/Mailman School of Public Health, New York, NY, ³Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, ⁴Rheumatology, Hospital for Special Surgery, New York, NY, ⁵Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁶Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁷Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY
Background/Purpose: Socioeconomic factors such as poverty may mediate racial disparities in health outcomes including those of total hip arthroplasty (THA), and confound analyses of differences…
Abstract Number: 312 • 2017 ACR/ARHP Annual Meeting
Rates of Total Joint Replacement Utilization in the U.S.: Future Projections to 2020-2040 Using the National Inpatient Sample
Jasvinder A. Singh and Shaohua Yu, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: To project the future utilization of total hip and knee joint arthroplasty (THA, TKA).Methods: We used the 2000-2010 U.S. National Inpatient Sample combined with…
Abstract Number: 977 • 2017 ACR/ARHP Annual Meeting
Association of Leisure-Time Physical Activity with Late-Life Mobility Limitation Among Women with Total Joint Replacement for Hip or Knee Osteoarthritis
Aladdin Shadyab¹, Wenjun Li², Charles Eaton³ and Andrea LaCroix⁴, ¹Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, ²Medicine, University of Massachusetts Medical School, Worcester, MA, ³Family Medicine and Epidemiology, Warren Alpert Medical School, School of Public Health, Brown University, Providence, RI, ⁴Family Medicine and Public Health, University of California, San Diego School of Medicine, La Jolla, CA
Background/Purpose: Maintaining mobility in old age is an important public health goal for patients with hip or knee osteoarthritis (OA), who are vulnerable to functional…
Abstract Number: 986 • 2016 ACR/ARHP Annual Meeting
Sex-Specific Associations Between Improvement in Gait Mechanics and Improvement in Pain, Function, and Abductor Strength after Total Hip Arthroplasty
J. Heather Brunner¹ and Kharma C. Foucher², ¹Physical Therapy, University of Illinois at Chicago, Chicago, IL, ²Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL
Background/Purpose: There are sex disparities in both utilization and outcomes of total hip arthroplasty (THA).1 Identification of sex-specific biomechanical factors related to outcomes could lead…
Abstract Number: 1520 • 2016 ACR/ARHP Annual Meeting
RA Flare after Total Hip and Total Knee Arthroplasty: Preliminary Outcomes at 1 Year
Susan M. Goodman¹, Susan J. Bartlett², Ryan Cummings³, Kathleen Andersen³, Edward F. DiCarlo⁴, Mark P. Figgie⁵, Laura T. Donlin⁶, Dana E. Orange⁷ and Vivian P. Bykerk⁸, ¹Medicine, Hospital for Special Surgery, New York, NY, ²Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ³Hospital for Special Surgery, New York, NY, ⁴Laboratory Medicine, Hospital for Special Surgery, New York, NY, ⁵Orthopaedics, Hospital for Special Surgery, New York, NY, ⁶Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, ⁷Rheumatology, Hospital for Special Surgery, New York, NY, ⁸Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Post-op flares are frequent for RA patients after total hip (THA) and total knee arthroplasty (TKA), when medications are discontinued to mitigate infection…
Abstract Number: 2052 • 2016 ACR/ARHP Annual Meeting
Preoperative Timing of Infliximab and Risk of Post-Operative Infection in a Medicare Cohort
Michael D. George¹, Joshua F. Baker¹, Jesse Yenchih Hsu², Qufei Wu³, Fenglong Xie⁴, Lang Chen⁴, Huifeng Yun⁵ and Jeffrey Curtis⁶, ¹Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Biostatistics, University of Pennsylvania, Philadelphia, PA, ³Biostatistics and Analysis Center, University of Pennsylvania, Philadelphia, PA, ⁴Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁵Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, ⁶Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Patients taking biologic DMARDs often undergo elective surgery, but data to guide if and when to hold biologics before surgery is limited. This study…
Abstract Number: 2331 • 2016 ACR/ARHP Annual Meeting
Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis
Jasvinder A. Singh¹, Bradley Young², Shawna Watson³, jorge perez², Gerald McGwin² and Brent Ponce², ¹Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³university of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The purpose of this study was to analyze time-trends in various types of total joint arthroplasty (TJA) and assess if the proportion of the…
Abstract Number: 1281 • 2015 ACR/ARHP Annual Meeting
Reduction in Rural-Urban Disparity in Discharge Disposition to Home after Total Knee Arthroplasty in the U.S
Jasvinder A. Singh and Rekha Ramachandaran, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Rural-urban disparities in outcomes after total joint arthroplasty are of great interest, given the differences in health care access and social support between those…
Abstract Number: 1417 • 2015 ACR/ARHP Annual Meeting
Rural Residence Does Not Impact Total Ankle Arthroplasty Utilization and Outcomes
Jasvinder A. Singh and Rekha Ramachandaran, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: It is not known whether there are rural-urban disparities in Total Ankle Arthroplasty (TAA), given that TAA is a relatively new procedure and…
Abstract Number: 1418 • 2015 ACR/ARHP Annual Meeting
The Importance of Comorbidity in Understanding the 6-Month Trajectories of Pain and Function after Total Hip Arthroplasty
C. Allyson Jones¹, Gian S. Jhangri², Lauren A. Beaupre¹ and Maria E. Suarez-Almazor³, ¹Physical Therapy, University of Alberta, Edmonton, AB, Canada, ²School of Public Health, University of Alberta, Edmonton, AB, Canada, ³General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
Background/Purpose: Osteoarthritis (OA) is chronic condition associated with a number of other comorbidities which may affect the 6 month pattern of recovery of total hip…
Abstract Number: 1490 • 2015 ACR/ARHP Annual Meeting
Can Patients Forget Their Artificial Joint after Arthroplasty?
Gizem Irem KINIKLI¹, Hande GUNEY², Sercan ONAL², Ceyda SARIAL², Dilara DONDER², Inci YUKSEL², Omur CAGLAR³ and Gulay KINIKLI⁴, ¹Department of Physiotherapy and Rehabilitation, Hacettepe University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Ankara, Turkey, ²Department of Physiotherapy and Rehabilitation, Hacettepe University, Faculty of Health Sciences, Ankara, Turkey, ³Department of Orthopedics and Traumatology, Hacettepe University, Faculty of Medicine, Ankara, Turkey, ⁴Department of Rheumatology, Ankara University, Faculty of Medicine, Ankara, Turkey
Background/Purpose: Knee and hip osteoarthritis (OA) are the clinical outcome of a functional and structural failure resulting with pain and physical dysfunction. Total joint arthroplasty…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].